Stock Scorecard
Stock Summary for Ascendis Pharma A/S (ASND) - $270.45 as of 7/13/2026 1:23:57 PM EST
Total Score
10 out of 30
Safety Score
56 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for ASND
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for ASND
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for ASND
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for ASND
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for ASND (56 out of 100)
| Stock Price Rating (Max of 10) | 10 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 10 |
| Book Value (Max of 10) | 4 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 3 |
| Trading Volume (Max of 10) | 5 |
| Price to Earnings (Max of 10) | 5 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for ASND
Financial Details for ASND
Company Overview |
|
|---|---|
| Ticker | ASND |
| Company Name | Ascendis Pharma A/S |
| Country | USA |
| Description | Ascendis Pharma A / S, a biopharmaceutical company, develops therapies for unmet medical needs. The company is headquartered in Hellerup, Denmark. |
| Sector Name | HEALTHCARE |
| Industry Name | BIOTECHNOLOGY |
| Most Recent Quarter | 3/31/2026 |
| Next Earnings Date | 8/6/2026 |
Stock Price History |
|
| Last Day Price | 270.45 |
| Price 4 Years Ago | 122.13 |
| Last Day Price Updated | 7/13/2026 1:23:57 PM EST |
| Last Day Volume | 375,370 |
| Average Daily Volume | 849,824 |
| 52-Week High | 282.15 |
| 52-Week Low | 160.86 |
| Last Price to 52 Week Low | 68.13% |
Valuation Measures |
|
| Trailing PE | 31.34 |
| Industry PE | 98.16 |
| Sector PE | 99.45 |
| 5-Year Average PE | 10.14 |
| Free Cash Flow Ratio | 30.94 |
| Industry Free Cash Flow Ratio | 26.56 |
| Sector Free Cash Flow Ratio | 28.52 |
| Current Ratio Most Recent Quarter | 1.00 |
| Total Cash Per Share | 8.74 |
| Book Value Per Share Most Recent Quarter | 8.97 |
| Price to Book Ratio | 31.93 |
| Industry Price to Book Ratio | 12.29 |
| Sector Price to Book Ratio | 13.70 |
| Price to Sales Ratio Twelve Trailing Months | 20.49 |
| Industry Price to Sales Ratio Twelve Trailing Months | 10.58 |
| Sector Price to Sales Ratio Twelve Trailing Months | 27.48 |
| Analyst Buy Ratings | 14 |
| Analyst Strong Buy Ratings | 4 |
Share Statistics |
|
| Total Shares Outstanding | 65,593,000 |
| Market Capitalization | 17,739,626,850 |
| Institutional Ownership | 102.41% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | 42.07% |
| Reported EPS 12 Trailing Months | 8.63 |
| Reported EPS Past Year | 0.27 |
| Reported EPS Prior Year | -4.06 |
| Net Income Twelve Trailing Months | 506,596,998 |
| Net Income Past Year | -219,034,140 |
| Net Income Prior Year | -378,084,000 |
| Quarterly Revenue Growth YOY | 144.30% |
| 5-Year Revenue Growth | 150.93% |
| Operating Margin Twelve Trailing Months | 10.10% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 573,417,383 |
| Total Cash Past Year | 615,778,613 |
| Total Cash Prior Year | 559,543,000 |
| Net Cash Position Most Recent Quarter | 187,311,383 |
| Net Cash Position Past Year | 230,524,613 |
| Long Term Debt Past Year | 385,254,000 |
| Long Term Debt Prior Year | 365,080,000 |
| Total Debt Most Recent Quarter | 386,106,000 |
| Equity to Debt Ratio Past Year | -0.73 |
| Equity to Debt Ratio Most Recent Quarter | 0.56 |
| Total Stockholder Equity Past Year | -162,751,650 |
| Total Stockholder Equity Prior Year | -105,706,000 |
| Total Stockholder Equity Most Recent Quarter | 488,481,897 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 42,107,474 |
| Free Cash Flow Per Share Twelve Trailing Months | 0.64 |
| Free Cash Flow Past Year | 43,619,717 |
| Free Cash Flow Prior Year | -307,624,000 |
Options |
|
| Put/Call Ratio | 0.41 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 11.29 |
| MACD Signal | 6.12 |
| 20-Day Bollinger Lower Band | 202.60 |
| 20-Day Bollinger Middle Band | 235.75 |
| 20-Day Bollinger Upper Band | 268.90 |
| Beta | 0.48 |
| RSI | 74.21 |
| 50-Day SMA | 215.76 |
| 150-Day SMA | 161.99 |
| 200-Day SMA | 147.22 |
System |
|
| Modified | 7/13/2026 5:45:08 PM EST |